50 Best Peptides

This website is for informational purposes only and does not constitute medical advice. Read disclaimer

#145

Galanin

NeuropeptideGALGalanin (1-30)

A 30-amino acid neuropeptide widely distributed in the nervous system, involved in pain modulation, feeding behavior, cognition, mood regulation, and neuroendocrine function.

Share:

Overview

Galanin is a 30-amino acid neuropeptide (29 amino acids in humans) discovered in 1983 by Viktor Mutt and colleagues in porcine intestinal extracts. Its name derives from its N-terminal glycine and C-terminal alanine residues. Galanin is widely distributed throughout the central and peripheral nervous systems, coexisting with several classical neurotransmitters including acetylcholine, serotonin, norepinephrine, and GABA in various neuronal populations.

Galanin acts through three G-protein coupled receptor subtypes: GalR1, GalR2, and GalR3. GalR1 and GalR3 are primarily inhibitory (Gi/Go-coupled), while GalR2 can couple to both inhibitory and excitatory pathways (Gq/G11). This receptor diversity allows galanin to exert varied and sometimes opposing effects depending on the tissue and receptor expression pattern. In the central nervous system, galanin generally acts as an inhibitory neuromodulator, reducing the release of other neurotransmitters.

In pain processing, galanin has a complex dual role. In normal conditions, galanin release from sensory neurons modulates nociceptive transmission. After nerve injury, galanin expression is dramatically upregulated in dorsal root ganglion neurons, where it appears to have both pronociceptive (via GalR2) and antinociceptive (via GalR1) effects depending on the specific pain model and site of action. This complexity has made galanin receptor-targeting drug development challenging but potentially rewarding.

Galanin is also implicated in cognition and Alzheimer's disease. Galanin-containing fibers hyperinnervate the basal forebrain cholinergic nuclei in Alzheimer's disease, and galanin inhibits acetylcholine release in the hippocampus. While this has been interpreted as galanin contributing to cognitive decline, some evidence suggests galanin may also have neuroprotective effects. Galanin's roles extend to feeding behavior (it stimulates fat intake), neuroendocrine regulation (modulating GH, prolactin, and insulin release), seizure modulation (anticonvulsant effects), and mood regulation.

Research Uses & Applications

  • Research into pain modulation and potential analgesic drug development through GalR1 agonism
  • Studied for neuroprotective roles in Alzheimer's disease and neurodegeneration
  • Investigated for anticonvulsant properties and epilepsy treatment potential
  • Research into feeding behavior regulation and fat intake control
  • Explored for mood regulation and potential antidepressant applications
  • Studied for neuroendocrine regulation including growth hormone and insulin modulation

Key Research Findings

  • Nerve injury models showed 50-120 fold upregulation of galanin in damaged dorsal root ganglion neurons, suggesting a role in neuropathic pain processing.
  • GalR1 agonists demonstrated analgesic effects in multiple pain models without the sedation associated with opioids.
  • Studies in galanin knockout mice showed increased seizure susceptibility, confirming galanin's anticonvulsant properties.
  • Alzheimer's disease brain studies revealed galanin hyperinnervation of basal forebrain cholinergic neurons, potentially contributing to cholinergic deficits.
  • Central administration of galanin in rodents specifically increased fat intake without affecting total caloric consumption, suggesting a macronutrient-specific appetite effect.

Risks & Side Effects

  • Galanin is not used as a therapeutic agent; it is a research tool and drug target.
  • Central galanin administration causes cognitive impairment through inhibition of cholinergic transmission.
  • Complex and sometimes opposing effects at different receptor subtypes complicate therapeutic development.
  • Exogenous administration may alter feeding behavior, neuroendocrine function, and nociception in unpredictable ways.
  • Available only as a research reagent; not suitable for human therapeutic use.

Administration

Used exclusively in research settings. In animal studies, galanin is administered intracerebroventricularly (0.1-10 nmol), intrathecally, or by local tissue injection. Cell culture studies use nanomolar to micromolar concentrations. No human therapeutic administration protocols exist. Available as a research peptide from scientific suppliers.

Legal Status

Available as a research chemical. Not approved by the FDA or any regulatory agency for therapeutic use. GalR1 agonists and GalR3 antagonists are in preclinical pharmaceutical development. Not a controlled substance.

Frequently Asked Questions

What is Galanin?

A 30-amino acid neuropeptide widely distributed in the nervous system, involved in pain modulation, feeding behavior, cognition, mood regulation, and neuroendocrine function.

What are the main uses of Galanin?

The primary research applications of Galanin include: Research into pain modulation and potential analgesic drug development through GalR1 agonism; Studied for neuroprotective roles in Alzheimer's disease and neurodegeneration; Investigated for anticonvulsant properties and epilepsy treatment potential; Research into feeding behavior regulation and fat intake control; Explored for mood regulation and potential antidepressant applications; Studied for neuroendocrine regulation including growth hormone and insulin modulation.

What are the risks and side effects of Galanin?

Documented risks and side effects include: Galanin is not used as a therapeutic agent; it is a research tool and drug target.; Central galanin administration causes cognitive impairment through inhibition of cholinergic transmission.; Complex and sometimes opposing effects at different receptor subtypes complicate therapeutic development.; Exogenous administration may alter feeding behavior, neuroendocrine function, and nociception in unpredictable ways.; Available only as a research reagent; not suitable for human therapeutic use.. Always consult a healthcare professional before considering any peptide.

Is Galanin legal?

Available as a research chemical. Not approved by the FDA or any regulatory agency for therapeutic use. GalR1 agonists and GalR3 antagonists are in preclinical pharmaceutical development. Not a controlled substance.

How is Galanin administered?

Used exclusively in research settings. In animal studies, galanin is administered intracerebroventricularly (0.1-10 nmol), intrathecally, or by local tissue injection. Cell culture studies use nanomolar to micromolar concentrations. No human therapeutic administration protocols exist. Available as a research peptide from scientific suppliers.

Related Peptides

Stay Updated on Peptide Research

Get the latest peptide research news and updates delivered to your inbox.

Important Disclaimer

The information on this page is for educational and informational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before considering any peptide or supplement. 50 Best Limited does not endorse, recommend, or promote the use of any peptide for self-administration. Read our full disclaimer.